References

Rowland M, Fleming P, Bourke B. Looking in the mouth for Crohn's disease. Inflamm Bowel Dis. 2010; 16:332-337
Saalman R, Mattsson U, Jontell M. Orofacial granulomatosis in childhood – a clinical entity that may indicate Crohn's disease as well as food allergy. Acta Paediatr. 2009; 98:1162-1167
Challacombe SJ. Oro-facial granulomatosis and oral Crohns disease: are they specific diseases and do they predict systemic Crohns disease?. Oral Dis. 1997; 3:127-129
Wiesenfeld D, Ferguson MM, Mitchell DN Oro-facial granulomatosis – a clinical and pathological analysis. Q J Med. 54:101-113
McCartan BE, Healy CM, McCreary CE, Flint SR, Rogers S, Toner ME. Characteristics of patients with orofacial granulomatosis. Oral Dis. 2011; 17:696-704
Lazzerini M, Bramuzzo M, Ventura A. Association between orofacial granulomatosis and Crohn's disease in children: systematic review. World J Gastroenterol. 2014; 20:7497-7504
Al-Hamad A, Porter S, Fedele S. Orofacial granulomatosis. Dermatol Clin. 2015; 33:433-446
Campbell H, Escudier M, Patel P Distinguishing orofacial granulomatosis from crohn's disease: two separate disease entities?. Inflamm Bowel Dis. 2011; 17:2109-2115
Al Johani KA, Moles DR, Hodgson TA, Porter SR, Fedele S. Orofacial granulomatosis: clinical features and long-term outcome of therapy. J Am Acad Dermatol. 2010; 62:611-620
Al Johani K, Moles DR, Hodgson T, Porter SR, Fedele S. Onset and progression of clinical manifestations of orofacial granulomatosis. Oral Dis. 2009; 15:214-219
Grave B, McCullough M, Wiesenfeld D. Orofacial granulomatosis – a 20-year review. Oral Dis. 2009; 15:46-51
Miest R, Bruce A, Rogers RS. Orofacial granulomatosis. Clin Dermatol. 2016; 34:505-513
Campbell H, Escudier MP, Brostoff J Dietary intervention for oral allergy syndrome as a treatment in orofacial granulomatosis: a new approach?. J Oral Pathol Med. 2013; 42:517-522
Tilakaratne WM, Freysdottir J, Fortune F. Orofacial granulomatosis: review on aetiology and pathogenesis. J Oral Pathol Med. 2008; 37:191-195
Gibson J, Wray D. Human leucocyte antigen typing in orofacial granulomatosis. Br J Dermatol. 2000; 143:1119-1121
Freysdottir J, Zhang S, Tilakaratne WM, Fortune F. Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis. 2007; 13:439-445
Fitzpatrick L, Healy CM, McCartan BE, Flint SR, McCreary CE, Rogers S. Patch testing for food-associated allergies in orofacial granulomatosis. J Oral Pathol Med. 2011; 40:10-13
Armstrong DK, Biagioni P, Lamey PJ, Burrows D. Contact hypersensitivity in patients with orofacial granulomatosis. Am J Contact Derm. 1997; 8:35-38
White A, Nunes C, Escudier M Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet. Inflamm Bowel Dis. 2006; 12:508-514
Patel P, Brostoff J, Campbell H Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clin Transl Allergy. 2013; 3
Apaydin R, Bahadir S, Kaklikkaya N, Kakklikkaya N, Bilen N, Bayramgürler D. Possible role of Mycobacterium tuberculosis complex in Melkersson-Rosenthal syndrome demonstrated with Gen-Probe amplified Mycobacterium tuberculosis direct test. Australas J Dermatol. 2004; 45:94-99
Muellegger RR, Weger W, Zoechling N Granulomatous cheilitis and Borrelia burgdorferi: polymerase chain reaction and serologic studies in a retrospective case series of 12 patients. Arch Dermatol. 2000; 136:1502-1506
Savage NW, Barnard K, Shirlaw PJ Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease. Clin Exp Immunol. 2004; 135:483-489
Shetty AK, Gedalia A. Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online J. 2008; 6
Suresh L, Radfar L. Oral sarcoidosis: a review of literature. Oral Dis. 2005; 11:138-145
Ziem PE, Pfrommer C, Goerdt S, Orfanos CE, Blume-Peytavi U. Melkersson-Rosenthal syndrome in childhood: a challenge in differential diagnosis and treatment. Br J Dermatol. 2000; 143:860-863
Sciubba JJ, Said-Al-Naief N. Orofacial granulomatosis: presentation, pathology and management of 13 cases. J Oral Pathol Med. 2003; 32:576-585
Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L. The multiform and variable patterns of onset of orofacial granulomatosis. J Oral Pathol Med. 2003; 32:200-205
Campbell HE, Escudier MP, Patel P, Challacombe SJ, Sanderson JD, Lomer MC. Review article: cinnamon- and benzoate-free diet as a primary treatment for orofacial granulomatosis. Aliment Pharmacol Ther. 2011; 34:687-701
Casson DH, Eltumi M, Tomlin S, Walker-Smith JA, Murch SH. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut. 2000; 47:436-440
Simmonds J, Grundy N, Trompeter R, Tullus K. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome. Arch Dis Child. 2010; 95:146-149
Tuxen AJ, Orchard D. Childhood and adolescent orofacial granulomatosis is strongly associated with Crohn's disease and responds to intralesional corticosteroids. Australas J Dermatol. 2010; 51:124-127
Mentzer A, Goel R, Elliott T Azathioprine is effective for oral involvement in Crohn's disease but not for orofacial granulomatosis alone. J Oral Pathol Med. 2016; 45:312-318
Eustace K, Clowry J, Kirby B, Lally A. Thalidomide in the treatment of refractory orofacial granulomatosis. Br J Dermatol. 2014; 171:423-425
O'Neill ID, Scully C. Biologics in oral medicine: oral Crohn's disease and orofacial granulomatosis. Oral Dis. 2012; 18:633-638
Tan O, Atik B, Calka O. Plastic surgical solutions for melkersson-rosenthal syndrome: facial liposuction and cheiloplasty procedures. Ann Plast Surg. 2006; 56:268-273

Orofacial granulomatosis in children − a review

From Volume 46, Issue 1, January 2019 | Pages 42-48

Authors

Maalini Patel

BDS(Hons), MPaedDent RCSEng, FDS RCSEng

Specialty Registrar in Paediatric Dentistry, Guy's and St Thomas' NHS Foundation Trust, Bristol, UK

Articles by Maalini Patel

Gemma Davis

BDS, MFDSRCS (Eng), PgCertTLHP

Specialty Registrar in Oral Medicine, University Hospitals Bristol NHS Foundation Trust, Bristol, UK

Articles by Gemma Davis

Rebecca John

BDS, MPaed Dent RCS(Ed), FDS RCS(Ed)

Consultant Senior Lecturer in Paediatric Dentistry, University Hospitals Bristol NHS Foundation Trust, Bristol, UK

Articles by Rebecca John

Rachel Cowie

BDS, MBChB MFDS RCS(Ed) FDS(OM) RCS(Ed)

Consultant in Oral Medicine, University Hospitals Bristol NHS Foundation Trust, Bristol, UK

Articles by Rachel Cowie

Abstract

Abstract: Orofacial granulomatosis (OFG) is an uncommon chronic inflammatory disorder that can present in childhood. It has a range of clinical manifestations with the common features being lip swelling and oral ulceration. It can be idiopathic or associated with systemic granulomatous conditions such as Crohn's disease and sarcoidosis. Patients presenting with features suggestive of OFG, with or without gastrointestinal symptoms, should be referred promptly to secondary care. The management of OFG is often challenging and includes dietary restrictions; topical, intralesional and systemic corticosteroids; and other systemic immunomodulatory drugs. This condition can lead to significant psychological morbidity for the child if left untreated.

CPD/Clinical Relevance: Orofacial granulomatosis can present in childhood and its features may be first noted on routine check-up with a general dental practitioner (GDP).

Article

Orofacial granulomatosis (OFG) is a rare condition affecting both children and adults. It is characterized by granulomatous lesions affecting the orofacial region. It can appear as an isolated condition, the true definition of OFG.1 It is a diagnosis of exclusion as its features can present in conjunction with systemic granulomatous disorders such a Crohn's Disease (CD) and sarcoidosis.2 There has been speculation that OFG may be a predictor of future CD when seen in children.3 This article will focus on the paediatric patient presenting with clinical features of orofacial granulomatous lesions, including those later found to have CD.

Orofacial granulomatosis was first described in 1985 by Weisenfeld et al, who reported 60 cases presenting with lymphoedema and the presence of multiple non-caseating giant cell granulomatous lesions.4 It is closely related to Melkersson-Rosenthal syndrome which describes the triad of persistent lip or facial swelling, recurrent facial paralysis and fissured tongue.1

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available